JY
DSGN icon

Jeff Yass’s Design Therapeutics DSGN Stock Holding History

Jeff Yass’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+15,650
New +$195K ﹤0.01% 11682
2026
Q1 		– Sell
-61,852
Closed -$580K – 13359
2025
Q4 		$580K Buy
61,852
+47,829
+341% +$375K ﹤0.01% 8445
2025
Q3 		$106K Sell
14,023
-24,147
-63% -$121K ﹤0.01% 11539
2025
Q2 		$129K Sell
38,170
-5,053
-12% -$18.9K ﹤0.01% 11617
2025
Q1 		$167K Buy
43,223
+5,911
+16% +$28.2K ﹤0.01% 11121
2024
Q4 		$230K Buy
+37,312
New +$216K ﹤0.01% 10403
2024
Q3 		– Sell
-21,726
Closed -$102K – 12190
2024
Q2 		$72.8K Buy
21,726
+10,494
+93% +$40.9K ﹤0.01% 11224
2024
Q1 		$45.3K Sell
11,232
-9,664
-46% -$25.8K ﹤0.01% 11590
2023
Q4 		$55.4K Sell
20,896
-1,641
-7% -$3.76K ﹤0.01% 11676
2023
Q3 		$53.2K Sell
22,537
-34,257
-60% -$160K ﹤0.01% 11274
2023
Q2 		$358K Sell
56,794
-247,275
-81% -$1.51M ﹤0.01% 9079
2023
Q1 		$1.75M Buy
304,069
+279,613
+1,143% +$2.09M ﹤0.01% 5432
2022
Q4 		$251K Buy
24,456
+6,140
+34% +$83.2K ﹤0.01% 9539
2022
Q3 		$306K Sell
18,316
-5,588
-23% -$111K ﹤0.01% 9743
2022
Q2 		$335K Buy
+23,904
New +$323K ﹤0.01% 9268

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's DSGN Position: Q2 2026 in Review

Jeff Yass opened a new position in Design Therapeutics (DSGN) in Q2 2026: 15,650 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #11682 among its holdings. This is a return to the name: Jeff Yass previously reported a position in DSGN as recently as Q4 2025.

Jeff Yass first reported a position in DSGN in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.75M in Q1 2023. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Jeff Yass held 15,650 shares of Design Therapeutics worth $226K as of Q2 2026.
  • Design Therapeutics was a new Jeff Yass position in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11682 holding.
  • Jeff Yass first reported a position in Design Therapeutics in Q2 2022 and has held it in 15 quarters since.
  • Jeff Yass's Design Therapeutics position peaked at $1.75M in Q1 2023.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.